Sponsor: Regeneron Pharmaceuticals, Inc.
Protocol R2810-ONC-1806. CemiplimAb Survivorship Epidemiology for patients with Cutaneous Squamous Cell Carcinoma.
For more information please contact the clinical research department: 631-675-5075
Protocol R2810-ONC-1806. CemiplimAb Survivorship Epidemiology for patients with Cutaneous Squamous Cell Carcinoma.
For more information please contact the clinical research department: 631-675-5075